Gyre Therapeutics
GYRE
#5353
Rank
A$1.81 B
Marketcap
$21.14
Share price
10.34%
Change (1 day)
-45.92%
Change (1 year)

Gyre Therapeutics (GYRE) Fails to deliver data

Key failure to deliver metrics for Gyre Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gyre Therapeutics (GYRE) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gyre Therapeutics (GYRE) - since 2023

Volume in USD (price x number of shares), data since 2023

Gyre Therapeutics (GYRE) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024A$9.69 M223.95%
2023A$2.99 M